Catalent, Inc.
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Techno…
Drug Manufacturers - Specialty & Generic
US, Somerset [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Catalent, Inc. (CTLT) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug Manufacturers—Specialty & Generic Average | - - | - - | - - | 232,043.44 | 39,617.95 | 1,616.38 | 59,358.76 | -434.46 | 0.01 | 43.6656 | 82.67 | 0.4389 | -0.3629 | 0.01 | 0.02 | 2.3969 | - - | ||
| Maximum | - - | - - | - - | 8,626,028.00 | 528,312.00 | 32,061.00 | 1,988,352.00 | 16,134.00 | 0.08 | 2,279.6263 | 3,215.80 | 1.0000 | 1.6542 | 0.13 | 1.46 | 35.1990 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 0.00 | -15,489.00 | -277,041.00 | -30,106.00 | 0.00 | -1,306.5021 | -853.08 | -3.9254 | -42.3731 | -0.31 | -0.90 | 0.0000 | - - | ||
| Catalent, Inc. CTLT | 60.98 | 1.32 2.21% | 4,869 vs. 1,690 | 11,068.00 | 1,074.00 | -101.00 | -62.00 | -804.00 | -0.5500 | -25.4034 | 0.0000 | 0.2132 | -0.0940 | -0.0280 | -0.0102 | 1.5571 | 181.00 | ||
| Bio-Rad Laboratories, Inc. BIO-B | 334.85 | 0.00 0.00% | 0 vs. 0 | 9,322.00 | 610.00 | 383.00 | 28.00 | 9,644.00 | 13.4600 | 6.2950 | 0.0000 | 0.5345 | 0.6285 | 0.0424 | 0.0304 | 4.5283 | 27.00 | ||
| Teleflex Incorporated TFX | 191.71 | 1.07 0.56% | 249 vs. 367 | 8,903.00 | 737.00 | 15.00 | 72.00 | 4,109.00 | 0.3200 | 171.5370 | 0.0015 | 0.5640 | 0.0207 | 0.0034 | 0.0020 | 1.2343 | 46.00 | ||
| IQVIA Holdings Inc. IQV | 201.82 | 4.22 2.14% | 1,869 vs. 1,427 | 36,630.00 | 3,740.00 | 288.00 | 377.00 | 4,980.00 | 1.5800 | 39.2964 | 0.0000 | 0.2759 | 0.0770 | 0.0454 | 0.0108 | 0.7810 | 181.00 | ||
| Charles River Laboratories International, Inc. CRL | 195.77 | 1.58 0.81% | 575 vs. 718 | 10,010.00 | 1,011.00 | 67.00 | 50.00 | 1,959.00 | 1.4200 | 51.7491 | 0.0000 | 0.3165 | 0.0666 | 0.0185 | 0.0083 | 1.1776 | 51.00 | ||
| West Pharmaceutical Services, Inc. WST | 316.59 | -4.29 -1.34% | 485 vs. 593 | 22,928.00 | 695.00 | 115.00 | 27.00 | 3,624.00 | 1.5700 | 63.0997 | 0.0005 | 0.3310 | 0.1658 | 0.0430 | 0.0320 | 1.7363 | 72.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.